NCT02389491View on ClinicalTrials.gov

Effect of a High Density Formula on Growth and Safety in Congenital Heart Disease Infants

NACompletedINTERVENTIONAL
Enrollment

64

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 31, 2015

Study Completion Date

October 31, 2015

Conditions
Congenital Heart Disease
Interventions
DIETARY_SUPPLEMENT

normal density formula (Necocate)

In control group,there are 32 infants

DIETARY_SUPPLEMENT

high density formula(Infatrini)

In intervention group,there are 32 infants

All Listed Sponsors
lead

Children's Hospital of Fudan University

OTHER

NCT02389491 - Effect of a High Density Formula on Growth and Safety in Congenital Heart Disease Infants | Biotech Hunter | Biotech Hunter